By Jonathan D. Rockoff and Cara Lombardo

Thermo Fisher Scientific Inc. is nearing a deal to buy pharmaceutical-testing company PPD Inc. for more than $15 billion, according to people familiar with the matter, in what would be the latest tie-up among companies that run clinical trials and provide other services for drugmakers.

The companies could finalize a deal as soon as this week, assuming the talks don't fall apart, the people said. PPD has a market value of about $13.6 billion, while Thermo Fisher's is $187 billion.

(More to come)

Write to Jonathan D. Rockoff at Jonathan.Rockoff@wsj.com and Cara Lombardo at cara.lombardo@wsj.com

(END) Dow Jones Newswires

April 14, 2021 16:02 ET (20:02 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
PPD (NASDAQ:PPD)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas PPD.
PPD (NASDAQ:PPD)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas PPD.